Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine whether sluggish cognitive tempo (SCT) symptomatology moderates dose response to methylphenidate and whether the impact of SCT on medication response is distinct from attention-deficit/hyperactivity disorder (ADHD) subtype effects. METHODS: Stimulant-naive children with ADHD predominantly inattentive type (ADHD-I; n = 126) or ADHD combined type (ADHD-C; n = 45) aged 7-11 years were recruited from the community from September 2006 to June 2013 to participate in a prospective, randomized, double-blind, 4-week crossover trial of long-acting methylphenidate. ADHD diagnosis and subtype were established according to DSM-IV criteria using a structured interview and teacher ADHD symptom ratings. SCT symptoms were assessed using a teacher-rated scale with 2 factors (Sluggish/Sleepy and Daydreamy). Primary outcomes included (1) categorization of children as methylphenidate responders, methylphenidate nonresponders, or placebo responders by 2 blinded physicians and (2) parent and teacher ratings of child behavior on the Vanderbilt ADHD Diagnostic Rating Scales while subjects were on treatment with placebo or 1 of 3 methylphenidate dosages (low, medium, high). RESULTS: Increased SCT Sluggish/Sleepy factor scores were associated with being a methylphenidate nonresponder or placebo responder rather than a methylphenidate responder (P = .04). Sluggish/Sleepy factor scores were also linked to diminished methylphenidate dose response for parent- and teacher-rated inattention symptoms (Sluggish/Sleepy factor × dose P = .004). SCT Daydreamy symptoms and ADHD subtype (ADHD-I vs ADHD-C) were not associated with methylphenidate responder status and did not moderate methylphenidate dose response for inattention symptoms. CONCLUSIONS: SCT Sluggish/Sleepy symptoms, but not SCT Daydreamy symptoms or ADHD subtype, predicted methylphenidate nonresponse. This novel finding, if replicated, may have important implications for assessing SCT as part of ADHD care. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01727414.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This distinction is further supported by evidence suggesting that the presence of CDS as the primary subtype of ADHD is associated with poor adherence to and limited efficacy of methylphenidate treatment.”
From Emotional Dysregulation and Cognitive Disengagement Syndrome: Exploring Their Relationship Through the Lens of Twin Studies (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, there are indications that CDS symptoms may predict a reduced response to methylphenidate in children with ADHD.”
The cited source says what the claim attributes to it.
In the citing paper
“Differences in study findings may also have been related to discrepancies in the sample composition. Ludwig et al. [58] exclusively examined whether CDS predicted the methylphenidate-ADHD treatment response among children with ADHD-I [58], whereas the two studies reported moderating effects (including children with both ADHD-C and ADHD-I) [51, 57].”
The cited source says what the claim attributes to it.
In the citing paper
“Froehlich et al. [57] also found methylphenidate dose response on parent- and teacher-reported inattentive, hyperactive-impulsive, and total ADHD symptoms was diminished for children who had more CDS sleepy/hypoactive symptoms [57].”
The cited source says what the claim attributes to it.
In the citing paper
“The discrepancy in findings by Ludwig et al. [58] and Fırat et al. [51] is further complicated by findings from a double-blind, randomized, placebo-controlled crossover trial by Froehlich et al. [57] which found only CDS-sleepy/hypoactive symptoms predicted diminished methylphenidate-treatment response rated by a clinician masked to treatment allocation (methylphenidate vs placebo) in 171 children”
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
Barkley, R. A. (2002) · PubMed · Cited by 737
Wolraich, M. L. (2003) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsg046 · Cited by 733
Barkley, R. A. (2013) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2012.734259 · Cited by 398
Becker, S. P., Leopold, D. R., Burns, G. L., Jarrett, M. A., Langberg, J. M., Marshall, S. A., McBurnett, K., Waschbusch, D. A., & Willcutt, E. G. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.12.006 · Cited by 368
Self-citationMcBurnett, K., Pfiffner, L. J., & Frick, P. J. (2001) · Journal of Abnormal Child Psychology · doi:10.1023/a:1010377530749 · Cited by 308
Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991) · Pediatrics · doi:10.1542/peds.87.4.519 · Cited by 281
Penny, A. M., Waschbusch, D. A., Klein, R. M., Corkum, P., & Eskes, G. (2009) · Psychological Assessment · doi:10.1037/a0016600 · Cited by 241
Stein, M. A., Sarampote, C. S., Waldman, I. D., Robb, A. S., Conlon, C., Pearl, P. L., Black, D. O., Seymour, K. E., & Newcorn, J. H. (2003) · Pediatrics · doi:10.1542/peds.112.5.e404 · Cited by 231
Self-citationObtaining Systematic Teacher Reports of Disruptive Behavior Disorders Utilizing DSM-IV
Wolraich, M. L., Feurer, I. D., Hannah, J. N., Baumgaertel, A., & Pinnock, T. Y. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022673906401 · Cited by 225
The Internal and External Validity of Sluggish Cognitive Tempo and its Relation with DSM–IV ADHD
Willcutt, E. G., Chhabildas, N., Kinnear, M., DeFries, J. C., Olson, R. K., Leopold, D. R., Keenan, J. M., & Pennington, B. F. (2014) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-013-9800-6 · Cited by 224
Hinshaw, S. P., Carte, E. T., Sami, N., Treuting, J. J., & Zupan, B. A. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.5.1099 · Cited by 198
Dimensions and Correlates of Attention Deficit/Hyperactivity Disorder and Sluggish Cognitive Tempo
Garner, A. A., Marceaux, J. C., Mrug, S., Patterson, C., & Hodgens, B. (2010) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-010-9436-8 · Cited by 168
Marshall, S. A., Evans, S. W., Eiraldi, R. B., Becker, S. P., & Power, T. J. (2014) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-013-9758-4 · Cited by 161
Self-citationBUITELAAR, J. K., VAN DER GAAG, R. J., SWAAB-BARNKVHLD, H., & KUIPKR, M. A. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199508000-00012 · Cited by 160
Becker, S. P., Marshall, S., & McBurnett, K. (2013) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-013-9825-x · Cited by 157
Self-citationBecker, S. P., & Langberg, J. M. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711435411 · Cited by 153
Self-citationBarbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., Leibson, C. L., & Jacobsen, S. J. (2014) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000099 · Cited by 152
A chart review study of the Inattentive and Combined Types of ADHD
Weiss, M., Worling, D., & Wasdell, M. (2003) · Journal of Attention Disorders · doi:10.1177/108705470300700101 · Cited by 138
McBurnett, K., Villodas, M., Burns, G. L., Hinshaw, S. P., Beaulieu, A., & Pfiffner, L. J. (2014) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-013-9801-5 · Cited by 130
Becker, S. P., Langberg, J. M., Luebbe, A. M., Dvorsky, M. R., & Flannery, A. J. (2014) · Journal of Clinical Psychology · doi:10.1002/jclp.22046 · Cited by 125
Self-citationPredicting the response of hyperkinetic children to stimulant drugs: A review
Barkley, R. A. (1976) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00922531 · Cited by 118
Becker, S. P., & Langberg, J. M. (2013) · Child Psychiatry & Human Development · doi:10.1007/s10578-013-0372-z · Cited by 111
Self-citationBecker, S. P., Luebbe, A. M., & Joyce, A. M. (2015) · Psychological Assessment · doi:10.1037/pas0000083 · Cited by 98
Self-citationFroehlich, T. E., Epstein, J. N., Nick, T. G., Melguizo Castro, M. S., Stein, M. A., Brinkman, W. B., Graham, A. J., Langberg, J. M., & Kahn, R. S. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.08.002 · Cited by 90
Self-citationSolanto, M., Newcorn, J., Vail, L., Gilbert, S., Ivanov, I., & Lara, R. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0033 · Cited by 80
Is the Inattentive Subtype of ADHD Different From the Combined/Hyperactive Subtype?
Grizenko, N., Paci, M., & Joober, R. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709347200 · Cited by 77
Topical review: sluggish cognitive tempo: research findings and relevance for pediatric psychology
Becker, S. P. (2013) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jst058 · Cited by 74
Self-citationDifferentiating SCT and inattentive symptoms in ADHD using fMRI measures of cognitive control
Fassbender, C., Krafft, C. E., & Schweitzer, J. B. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.05.007 · Cited by 72
Evaluating the Utility of Sluggish Cognitive Tempo in Discriminating Among DSM-IV ADHD Subtypes
Harrington, K. M., & Waldman, I. D. (2009) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-009-9355-8 · Cited by 70
Effects of Methylphenidate on Subtypes of Attention-Deficit/Hyperactivity Disorder
Gorman, E. B., Klorman, R., Thatcher, J. E., & Borgstedt, A. D. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000214191.57993.dd · Cited by 64
Tamm, L., Garner, A. A., Loren, R. E. A., Epstein, J. N., Vaughn, A. J., Ciesielski, H. A., & Becker, S. P. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.054 · Cited by 64
Self-citationFenollar Cortés, J., Servera, M., Becker, S. P., & Burns, G. L. (2017) · Journal of Attention Disorders · doi:10.1177/1087054714548033 · Cited by 63
Self-citationADHD Predominantly Inattentive Subtype With High Sluggish Cognitive Tempo: A New Clinical Entity?
Capdevila-Brophy, C., Artigas-Pallarés, J., Navarro-Pastor, J. B., García-Nonell, K., Rigau-Ratera, E., & Obiols, J. E. (2014) · Journal of Attention Disorders · doi:10.1177/1087054712445483 · Cited by 62
Burns, G. L., Becker, S. P., Servera, M., Bernad, M. D. M., & García-Banda, G. (2017) · Psychological Assessment · doi:10.1037/pas0000325 · Cited by 56
Self-citationCho, S.-C., Hwang, J., Kim, B., Lee, H., Kim, H., Lee, J.-S., Shin, M., & Lee, D.-S. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.011 · Cited by 46
Garner, A. A., Mrug, S., Hodgens, B., & Patterson, C. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711431456 · Cited by 43
Ludwig, H. T., Matte, B., Katz, B., & Rohde, L. A. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0115 · Cited by 36
Stockman, J. A. (2007) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70194-5 · Cited by 15
Expanding medication options for pediatric ADHD.
Froehlich, T. E., Delgado, S. V., & Anixt, J. S. (2013) · PubMed · Cited by 4
Self-citation
Research works printed but not linked: 2
- [3]Safer DJ, Zito JM. Pharmacoepidemiology of Methylphenidate and Other Stimulants for the Treatment of Attention Deficit Hyperactivity Disorder. In: Greenhill L, ed. Ritalin Theory and Practice 2nd ed. Larchmont, NY: Mary Ann Liebert, Inc.; 2000: 7– 26.
- [22]Wechsler D Wechsler Individual Achievement Test - Second Edition (WIAT-II) San Antonio, TX: Psychological Corporation; 2001.
Cited by
Becker, S. P., Willcutt, E. G., Leopold, D. R., Fredrick, J. W., Smith, Z. R., Jacobson, L. A., Burns, G. L., Mayes, S. D., Waschbusch, D. A., Froehlich, T. E., et al. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.07.821 · Cited by 175
Self-citationMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 164
Systematic Review: Assessment of Sluggish Cognitive Tempo Over the Past Decade
Becker, S. P. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.10.016 · Cited by 117
Self-citationBurns, G. L., & Becker, S. P. (2021) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2019.1678165 · Cited by 116
Self-citationBecker, S. P., & Willcutt, E. G. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1136-x · Cited by 85
“A recent medication trial of children with ADHD found that children with higher SCT (and sluggish/sleepy symptoms specifically) had less improvement in their ADHD symptoms across doses of methylphenidate (MPH) and were also more likely to be MPH nonresponders or placebo responders compared to other children with ADHD…”
Self-citation
Metadata
- Authors
- Froehlich, T. E., Becker, S. P., Nick, T. G., Brinkman, W. B., Stein, M. A., Peugh, J., & Epstein, J. N.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- University of Arkansas for Medical Sciences (US)
- Seattle Children's Hospital (US)
- Corresponding author
- Froehlich, Tanya E.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-04-25
- Volume
- 79
- Issue
- 2
- Pages
- 17m11553
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC6558969
- OpenAlex
- W2790278642
- Cited by
- 51
- References
- 42
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 3
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- Cincinnati Children's Hospital Medical Center
- University of Arkansas for Medical Sciences
- National Institute of Mental Health (K24MH064478, K23MH083881, K23MH083027, K23MH108603, R01MH070564, R01MH074770)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- sluggish cognitive tempo, methylphenidate response, attention deficit hyperactivity disorder, ADHD inattentive type, combined type ADHD, placebo response, dose-response relationship, inattentive symptoms, children, sleepiness, daydreaming
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child Behavior, Child, Preschool, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Fantasy, Female, Humans, Male, Methylphenidate, Psychiatric Status Rating Scales, Treatment Outcome, Drug Monitoring, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.